Virginia Nguyen1, Morgane Michel2, Helene Eltchaninoff3, Martine Gilard4, Christel Dindorf2, Bernard Iung1, Elias Mossialos5, Alain Cribier3, Alec Vahanian1, Karine Chevreul2, David Messika-Zeitoun6. 1. Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; INSERM U1148, Bichat Hospital, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. 2. Université Paris Diderot, Sorbonne Paris Cité, Paris, France; URC Eco Ile de France, Assistance Publique-Hôpitaux de Paris, Hôtel Dieu, Paris, France; INSERM, ECEVE, U1123, Paris, France. 3. Rouen University Hospital, INSERM U1096, FHU REMOD-VHF, Rouen, France. 4. Department of Cardiology, Brest University Hospital, Brest, France. 5. LSE Health, London School of Economics & Political Science, London, United Kingdom. 6. Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; INSERM U1148, Bichat Hospital, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: DMessika-zeitoun@ottawaheart.ca.
Abstract
BACKGROUND: Transcatheter aortic valve replacement (TAVR) has emerged as an alternative to surgical aortic valve replacement (SAVR), but unbiased data regarding evolution of the treatment of patients with aortic stenosis at the nationwide level are scarce. OBJECTIVES: This study sought to evaluate the number of aortic valve replacements (AVRs) performed in France, changes over time, and the effect of the adoption of TAVR. METHODS: Based on a French administrative hospital-discharge database, the study collected all consecutive AVRs performed in France between 2007 and 2015. RESULTS: A total of 131,251 interventions were performed: 109,317 (83%) SAVR and 21,934 (17%) TAVR. AVR linearly increased (from 10,892 to 18,704; p for trend <0.0001) mainly due to a marked increase in TAVR (from 244 to 6,722; p for trend = 0.0004), whereas SAVR remained stable (from 10,892 to 11,982; p for trend = 0.18). Parallel to a decrease in the Charlson index (p for trend <0.05), SAVR and TAVR in-hospital mortality rates significantly declined (both p for trend <0.01). The number of TAVRs significantly increased in all age categories (<75, 75 to 79, 80 to 84, and ≥85 years of age; all p for trend = 0.003), but reached or even exceeded SAVR in the 2 oldest categories. Although mortality rates declined for both isolated SAVR and TAVR, it became similar or slightly lower for TAVR than for isolated SAVR in 2015 in the 3 oldest age categories even if it did not reach statistical significance (p = 0.66, p = 0.47, and p = 0.06, respectively). CONCLUSIONS: The number of AVRs markedly increased in France between 2007 and 2015 due to the wide adoption of TAVR, which represented one-third of all AVRs in 2015. Patients' profile improved, suggesting that patients are referred earlier, and in-hospital mortality declined in all AVR subsets. Despite a worse clinical profile, the immediate outcome of TAVR compared favorably to isolated SAVR in patients >75 years of age. The results may have major implications for clinical practice and policymakers.
BACKGROUND: Transcatheter aortic valve replacement (TAVR) has emerged as an alternative to surgical aortic valve replacement (SAVR), but unbiased data regarding evolution of the treatment of patients with aortic stenosis at the nationwide level are scarce. OBJECTIVES: This study sought to evaluate the number of aortic valve replacements (AVRs) performed in France, changes over time, and the effect of the adoption of TAVR. METHODS: Based on a French administrative hospital-discharge database, the study collected all consecutive AVRs performed in France between 2007 and 2015. RESULTS: A total of 131,251 interventions were performed: 109,317 (83%) SAVR and 21,934 (17%) TAVR. AVR linearly increased (from 10,892 to 18,704; p for trend <0.0001) mainly due to a marked increase in TAVR (from 244 to 6,722; p for trend = 0.0004), whereas SAVR remained stable (from 10,892 to 11,982; p for trend = 0.18). Parallel to a decrease in the Charlson index (p for trend <0.05), SAVR and TAVR in-hospital mortality rates significantly declined (both p for trend <0.01). The number of TAVRs significantly increased in all age categories (<75, 75 to 79, 80 to 84, and ≥85 years of age; all p for trend = 0.003), but reached or even exceeded SAVR in the 2 oldest categories. Although mortality rates declined for both isolated SAVR and TAVR, it became similar or slightly lower for TAVR than for isolated SAVR in 2015 in the 3 oldest age categories even if it did not reach statistical significance (p = 0.66, p = 0.47, and p = 0.06, respectively). CONCLUSIONS: The number of AVRs markedly increased in France between 2007 and 2015 due to the wide adoption of TAVR, which represented one-third of all AVRs in 2015. Patients' profile improved, suggesting that patients are referred earlier, and in-hospital mortality declined in all AVR subsets. Despite a worse clinical profile, the immediate outcome of TAVR compared favorably to isolated SAVR in patients >75 years of age. The results may have major implications for clinical practice and policymakers.
Authors: Paolo Berretta; Luca Montecchiani; Fabio Vagnarelli; Mariano Cefarelli; Jacopo Alfonsi; Carlo Zingaro; Filippo Capestro; Michele D Pierri; Alessandro D'alfonso; Marco Di Eusanio Journal: Ann Cardiothorac Surg Date: 2020-09
Authors: Peter Stachon; Klaus Kaier; Andreas Zirlik; Wolfgang Bothe; Timo Heidt; Manfred Zehender; Christoph Bode; Constantin von Zur Mühlen Journal: J Am Heart Assoc Date: 2019-04-02 Impact factor: 5.501
Authors: Alexander Maier; Benedikt Hammerich; Frank Humburger; Thomas Brieschal; Timo Heidt; Wolfgang Bothe; Holger Schröfel; Klaus Kaier; Manfred Zehender; Jochen Reinöhl; Christoph Bode; Constantin von Zur Mühlen; Peter Stachon Journal: PLoS One Date: 2020-02-05 Impact factor: 3.240
Authors: Siyuan P Sheng; Paula D Strassle; Sameer Arora; Dhaval Kolte; Cassandra J Ramm; Kranthi Sitammagari; Avirup Guha; Madhu B Paladugu; Matthew A Cavender; John P Vavalle Journal: J Am Heart Assoc Date: 2019-01-22 Impact factor: 5.501
Authors: Matthias Lutz; David Messika-Zeitoun; Tanja K Rudolph; Eberhard Schulz; Jeetendra Thambyrajah; Guy Lloyd; Alexander Lauten; Norbert Frey; Jana Kurucova; Martin Thoenes; Cornelia Deutsch; Peter Bramlage; Richard Paul Steeds Journal: Open Heart Date: 2020-09